<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7943011/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <title>Changes in protein expression after metformin treatment and insulin supplementation.</title>
 </caption>
 <colgroup span="1">
  <col align="left" valign="middle" span="1"/>
  <col align="left" valign="middle" span="1"/>
 </colgroup>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">col0</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" colspan="2" rowspan="1">
    <b>proteins (15) affected by metformin treatment (|log</b>
    <sub>
     <b>2</b>
    </sub>
    <b>FC| ≥ 0.5), but not hyperinsulinemia (|log</b>
    <sub>
     <b>2</b>
    </sub>
    <b>FC| &lt; 0.5)</b>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">upregulated:</td>
   <td align="left" rowspan="1" colspan="1">AKT3, BDNF, CCL8, CCL28, CXCL12, ITGA2B, MIF</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">downregulated:</td>
   <td align="left" rowspan="1" colspan="1">ARVCF, CD3E, CD9, CD22, IL17A, KLK3, MKI67, RAD51C</td>
  </tr>
  <tr>
   <td align="left" colspan="2" rowspan="1">
    <b>proteins (15) with significantly differential expression due to metformin treatment (|log</b>
    <sub>
     <b>2</b>
    </sub>
    <b>FC| ≥ 0.5 and 
     <i>p</i> ≤ 0.05) 
    </b>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">upregulated:</td>
   <td align="left" rowspan="1" colspan="1">AKT3, CTSL, GFAP, GUSB, IL5, PI3, TFRC</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">downregulated:</td>
   <td align="left" rowspan="1" colspan="1">CCND2, CD63, CD81, IL1B, IL2, IL17A, IRF4, VTCN1</td>
  </tr>
  <tr>
   <td align="left" colspan="2" rowspan="1">
    <b>proteins (9) affected by hyperinsulinemia (|log</b>
    <sub>
     <b>2</b>
    </sub>
    <b>FC| ≥ 0.5), but not metformin treatment (|log</b>
    <sub>
     <b>2</b>
    </sub>
    <b>FC| &lt; 0.5)</b>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">upregulated:</td>
   <td align="left" rowspan="1" colspan="1">CTSD, PRSS3, SPP1</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">downregulated:</td>
   <td align="left" rowspan="1" colspan="1">CDH2, DKK3, FAF1, HBEGF, IGLC1, PGC</td>
  </tr>
  <tr>
   <td align="left" colspan="2" rowspan="1">
    <b>proteins (11) with significantly differential expression due to hyperinsulinemia (|log</b>
    <sub>
     <b>2</b>
    </sub>
    <b>FC| ≥ 0.5 and 
     <i>p</i> ≤ 0.05) 
    </b>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">upregulated:</td>
   <td align="left" rowspan="1" colspan="1">AMFR, CEACAM8, MPP3, PLCG2, SORL1, SPP1, VEGFA, WNT2B</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">downregulated:</td>
   <td align="left" rowspan="1" colspan="1">COL1A1, FAF1, IRS2</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn" id="t001fn001">
   <p>Compared to untreated control cells, metformin-treated cells differentially expressed 47 proteins, of which 15 were exclusively changed by the biguanide drug (and not hyperinsulinemia). Insulin-treated cells differentially expressed 40 proteins, of which 9 were exclusively changed by the pancreatic hormone (and not metformin).</p>
  </p>
 </tfoot>
</table>
